CTU Bern is an independent institution of the University of Bern.
It is the Clinical Trials Unit of the Faculty of Medicine of the University of Bern and the Inselspital, Bern University Hospital.
CTU Bern supports and collaborates in clinical studies primarily initiated by investigators of the University of Bern and collaborating institutions.
About us
CTU Bern is a unit of the University of Bern and primarily provides consulting, services and collaboration for clinical studies initiated by investigators of the University of Bern (including Inselspital) and other institutions. The aims of CTU Bern are:
  • to collaborate in clinical trials, epidemiological studies, and meta-analyses in any clinical field to strengthen and expand the evidence base for health care nationally and internationally,
  • to offer the scientific, technical and computing expertise needed to support patient-oriented clinical and epidemiological research at all stages, from conception to completion and dissemination,
  • to enable clinical researchers to comply with legal and regulatory requirements, and with internal, national, and international standards, including the International Conference on Harmonization for Good Clinical Practice Guidelines and the Declaration of Helsinki,
  • to ensure services provided are of the highest quality based on current knowledge and are provided in an effective and timely manner.

Research

S.No Title
1

CORON-ACT Study

The CORON-ACT study investigates the efficacy and safety of tocilizumab (Actemra®) in the treatment of severe coronavirus induced disease (COVID-19). CTU Bern is involved in designing, implementing, conducting, and analyzing the study.
2

HemMa Study

HemMa is a prospective cross-sectional observational study that aims to identify hematological markers in patients with sickle cell disease. The study is a collaboration between the Biologics Research Center of CSL Behring at SITEM and the Department of Hematology of the University Hospital (Inselspital) Bern. CTU Bern is involved in designing, implementing, conducting, and analyzing the study.
3

Simpl´HIV trial

The Simpl’HIV study investigated the outcomes of virologically-suppressed patients on standard combination antiretroviral therapy (cART) switching to DTG + emtricitabine (FTC) as well as the costs of a patient-centered ART monitoring.
3

BIOTOK Randomized Clinical Trial

Specially Designed Footwear Reduces Pain of Knee Osteoarthritis - First randomized clinical trial introduces new approach for treating the disease.